ES549981A0 - Procedimiento para preparar derivados de imidazol con acti- vidad antitrombotica - Google Patents

Procedimiento para preparar derivados de imidazol con acti- vidad antitrombotica

Info

Publication number
ES549981A0
ES549981A0 ES549981A ES549981A ES549981A0 ES 549981 A0 ES549981 A0 ES 549981A0 ES 549981 A ES549981 A ES 549981A ES 549981 A ES549981 A ES 549981A ES 549981 A0 ES549981 A0 ES 549981A0
Authority
ES
Spain
Prior art keywords
procedure
imidazole derivatives
thrombotic activity
preparing imidazole
preparing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES549981A
Other languages
English (en)
Other versions
ES8706127A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GD Searle LLC
Original Assignee
GD Searle LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by GD Searle LLC filed Critical GD Searle LLC
Publication of ES549981A0 publication Critical patent/ES549981A0/es
Publication of ES8706127A1 publication Critical patent/ES8706127A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
    • C07D213/30—Oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00—Ethers; Compounds having groups, groups or groups
    • C07C43/02—Ethers
    • C07C43/20—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring
    • C07C43/215—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring having unsaturation outside the six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00—Ethers; Compounds having groups, groups or groups
    • C07C43/02—Ethers
    • C07C43/20—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring
    • C07C43/23—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring containing hydroxy or O-metal groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
    • C07C51/347—Preparation of carboxylic acids or their salts, halides or anhydrides by reactions not involving formation of carboxyl groups
    • C07C51/353—Preparation of carboxylic acids or their salts, halides or anhydrides by reactions not involving formation of carboxyl groups by isomerisation; by change of size of the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
    • C07C51/347—Preparation of carboxylic acids or their salts, halides or anhydrides by reactions not involving formation of carboxyl groups
    • C07C51/367—Preparation of carboxylic acids or their salts, halides or anhydrides by reactions not involving formation of carboxyl groups by introduction of functional groups containing oxygen only in singly bound form
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40—Unsaturated compounds
    • C07C59/58—Unsaturated compounds containing ether groups, groups, groups, or groups
    • C07C59/64—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40—Unsaturated compounds
    • C07C59/58—Unsaturated compounds containing ether groups, groups, groups, or groups
    • C07C59/64—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings
    • C07C59/66—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings the non-carboxylic part of the ether containing six-membered aromatic rings
    • C07C59/68—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings the non-carboxylic part of the ether containing six-membered aromatic rings the oxygen atom of the ether group being bound to a non-condensed six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/088—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02—Compounds containing oxirane rings
    • C07D303/04—Compounds containing oxirane rings containing only hydrogen and carbon atoms in addition to the ring oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02—Compounds containing oxirane rings
    • C07D303/12—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
    • C07D303/18—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by etherified hydroxyl radicals
    • C07D303/20—Ethers with hydroxy compounds containing no oxirane rings
    • C07D303/22—Ethers with hydroxy compounds containing no oxirane rings with monohydroxy compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02—Compounds containing oxirane rings
    • C07D303/12—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
    • C07D303/18—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by etherified hydroxyl radicals
    • C07D303/20—Ethers with hydroxy compounds containing no oxirane rings
    • C07D303/24—Ethers with hydroxy compounds containing no oxirane rings with polyhydroxy compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D331/00—Heterocyclic compounds containing rings of less than five members, having one sulfur atom as the only ring hetero atom
    • C07D331/02—Three-membered rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Diabetes (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hematology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
ES549981A 1982-07-12 1985-12-16 Procedimiento para preparar derivados de imidazol con acti- vidad antitrombotica Expired ES8706127A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8220169 1982-07-12

Publications (2)

Publication Number Publication Date
ES549981A0 true ES549981A0 (es) 1987-06-01
ES8706127A1 ES8706127A1 (es) 1987-06-01

Family

ID=10531618

Family Applications (4)

Application Number Title Priority Date Filing Date
ES524021A Expired ES8504735A1 (es) 1982-07-12 1983-07-11 Procedimiento para preparar compuestos heterociclicos con actividad antitrombotica
ES539306A Expired ES8607958A1 (es) 1982-07-12 1985-01-02 Procedimiento para preparar derivados de imidazol con actividad antitrombotica.
ES549981A Expired ES8706127A1 (es) 1982-07-12 1985-12-16 Procedimiento para preparar derivados de imidazol con acti- vidad antitrombotica
ES557361A Expired ES8802450A1 (es) 1982-07-12 1987-01-30 Procedimiento para preparar derivado de imidazol con actividad antitrombotica

Family Applications Before (2)

Application Number Title Priority Date Filing Date
ES524021A Expired ES8504735A1 (es) 1982-07-12 1983-07-11 Procedimiento para preparar compuestos heterociclicos con actividad antitrombotica
ES539306A Expired ES8607958A1 (es) 1982-07-12 1985-01-02 Procedimiento para preparar derivados de imidazol con actividad antitrombotica.

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES557361A Expired ES8802450A1 (es) 1982-07-12 1987-01-30 Procedimiento para preparar derivado de imidazol con actividad antitrombotica

Country Status (7)

Country Link
EP (1) EP0105575B1 (es)
JP (1) JPS5951262A (es)
AU (1) AU566244B2 (es)
CA (1) CA1241329A (es)
DE (1) DE3369984D1 (es)
ES (4) ES8504735A1 (es)
ZA (1) ZA835036B (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA877650B (en) * 1986-10-14 1988-12-28 Searle & Co Alpha-(phenylalkyl)pyridinealkanol derivatives
DE4004061A1 (de) * 1990-02-10 1991-08-14 Hoechst Ag Neue imidazolverbindungen, verfahren zu deren herstellung, arzneimittel auf basis dieser verbindungen sowie einige zwischenprodukte
GB9127304D0 (en) * 1991-12-23 1992-02-19 Boots Co Plc Therapeutic agents
GB9312893D0 (en) * 1993-06-22 1993-08-04 Boots Co Plc Therapeutic agents

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2766238A (en) * 1952-12-18 1956-10-09 Hynson Westcott & Dunning Inc Amino compounds having antispasmodic properties
US4036844A (en) * 1972-04-04 1977-07-19 Beecham Group Limited Aryloxypyridines
MX3866E (es) * 1975-07-28 1981-08-26 Syntex Inc Metodo mejorado para preparar derivados de imidazoles n-alquil sustituidos
SE443783B (sv) * 1977-01-10 1986-03-10 Syntex Inc Sett att framstella 1-/2-(halofenyltio)-4-(p-klor-eller-fluorfenyl)-n-butyl/-imidazoler
JPS5951943B2 (ja) * 1978-08-21 1984-12-17 キツセイ薬品工業株式会社 新規なイミダゾ−ル誘導体
DK162882A (da) * 1981-04-13 1982-10-14 Searle & Co Imidazolderivater eller syreadditionssalte deraf,deres fremstilling og anvendelse

Also Published As

Publication number Publication date
DE3369984D1 (en) 1987-04-09
CA1241329A (en) 1988-08-30
AU1671583A (en) 1984-01-19
ZA835036B (en) 1984-08-29
ES8607958A1 (es) 1986-06-01
ES524021A0 (es) 1985-05-01
ES539306A0 (es) 1986-06-01
ES8504735A1 (es) 1985-05-01
ES557361A0 (es) 1988-06-01
EP0105575B1 (en) 1987-03-04
AU566244B2 (en) 1987-10-15
JPS5951262A (ja) 1984-03-24
EP0105575A1 (en) 1984-04-18
ES8802450A1 (es) 1988-06-01
ES8706127A1 (es) 1987-06-01

Similar Documents

Publication Publication Date Title
ES529174A0 (es) Procedimiento para la preparacion de derivados de imidazol
ES504257A0 (es) Procedimiento para la obtencion de derivados de imidazol trisustituidos
AR223315A1 (es) Procedimiento para la fabricacion de derivados de 2-guanidin-(tiazol o imidazol)
ES519657A0 (es) Procedimiento para preparar derivados de triazol e imidazol.
ES541660A0 (es) Procedimiento para preparar nuevos imidazoles
MX162759A (es) Procedimiento para preparar derivados de la cumarina
ES528181A0 (es) Procedimiento para la obtencion de derivados de imidazol (i,5-a)-piridina
ES536786A0 (es) Procedimiento para preparar derivados de imidazolina
ES552557A0 (es) Procedimiento para la obtencion de imidazoles sustituidos
ES549981A0 (es) Procedimiento para preparar derivados de imidazol con acti- vidad antitrombotica
ES543286A0 (es) Procedimiento para preparar nuevos derivados de imidazol
MX160579A (es) Procedimiento para producir derivados de hidantoina
ES511317A0 (es) Procedimiento para preparar derivados de imidazol.
ES524424A0 (es) Procedimiento para la obtencion de derivados carbapenem fluoralquilados
ES530042A0 (es) Procedimiento para la obtencion de derivados de imidazol conteniendo azufre
ES531021A0 (es) Procedimiento para preparar derivados de triazol e imidazol
MX4907E (es) Procedimiento para preparar derivados de imidazol
MX6968E (es) Procedimiento para preparar salicilato de imidazol
ES524920A0 (es) Un procedimiento para preparar derivados de imidazol
ES530681A0 (es) Procedimiento para preparar derivados de (indenil-2)-2-imidazolina
ES501700A0 (es) Procedimiento para la preparacion de derivados de imidazol
ES502162A0 (es) Procedimiento para la obtencion de derivados del imidazol.
ES529963A0 (es) Procedimiento para la preparacion de un compuesto de imidazol
ES505322A0 (es) Procedimiento para la preparacion de derivados de imidazol
ES509249A0 (es) Procedimiento para preparar derivados de imidazol.